Product Information
PSEUDOEPHEDRINE ER 120 MG TAB is a generic product labeled by Ohm Laboratories Inc., priced at $0.2811 per EA under NDC 51660049221. Its NADAC has been published 49 times since Oct 29, 2025.
FDA first approved this application on Sep 28, 2005.
Strength
120 mg/1
Manufacturer
Ohm Laboratories Inc.NDC
51660049221
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077442FDA Approved
9/28/2005
On Market Since
4/28/2006
Pharmacological Classes
Price Statistics
The NADAC for PSEUDOEPHEDRINE ER 120 MG TAB has been published 49 times since Oct 29, 2025, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2811 per EA |
|---|---|
| All-time high | $0.2869 (Jun 10, 2026) |
| All-time low | $0.2621 (Nov 19, 2025) |
| 52-week high | $0.2869 |
| 52-week low | $0.2621 |
| Median price | $0.2805 |
| Average price | $0.2772 |
| Largest weekly change | +2.7% (Jan 21, 2026) |
| Weeks tracked | 49 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pseudoephedrine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ohm Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pseudoephedrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PSEUDOEPHEDRINE ER 120 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PSEUDOEPHEDRINE ER 120 MG TAB, manufactured by Ohm Laboratories Inc., is $0.2811 per EA (NDC 51660049221), effective Sep 30, 2026.
How has the price of PSEUDOEPHEDRINE ER 120 MG TAB changed over time?
Over the history we have for it, the NADAC for PSEUDOEPHEDRINE ER 120 MG TAB has risen 5.5%. It has been tracked across 49 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for PSEUDOEPHEDRINE ER 120 MG TAB?
Since Oct 29, 2025, the NADAC for PSEUDOEPHEDRINE ER 120 MG TAB has ranged from a low of $0.2621 (Nov 19, 2025) to a high of $0.2869 (Jun 10, 2026), with a median of $0.2805 per EA.
Are there cheaper alternatives to PSEUDOEPHEDRINE ER 120 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of PSEUDOEPHEDRINE ER 120 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PSEUDOEPHEDRINE ER 120 MG TAB?
PSEUDOEPHEDRINE ER 120 MG TAB (NDC 51660049221) is labeled by Ohm Laboratories Inc., and CMS classifies it as a generic product.